1. Extracellular HMGB1 interacts with RAGE and promotes chemoresistance in acute leukemia cells
    Weixin Lai et al, 2021, Cancer Cell International CrossRef
  2. Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance
    Dong-Yu Wang et al, 2016, Chinese Journal of Cancer CrossRef
  3. ATG 4B Serves a Crucial Role in RCE-4-Induced Inhibition of the Bcl-2–Beclin 1 Complex in Cervical Cancer Ca Ski Cells
    Fang-Fang You et al, 2021, International Journal of Molecular Sciences CrossRef
  4. Dengue virus induced autophagy is mediated by HMGB1 and promotes viral propagation
    Nidhi Chaudhary et al, 2023, International Journal of Biological Macromolecules CrossRef
  5. Multiple functions of HMGB1 in cancer
    Guangyao Lv et al, 2024, Frontiers in Oncology CrossRef
  6. High mobility group box 1 promotes sorafenib resistance in HepG2 cells and in vivo
    Yinzong Xiao et al, 2017, BMC Cancer CrossRef
  7. Autophagic degradation of CCN2 (cellular communication network factor 2) causes cardiotoxicity of sunitinib
    Zhifei Xu et al, 2022, Autophagy CrossRef
  8. Understanding the Role of Autophagy in Cancer Formation and Progression Is a Real Opportunity to Treat and Cure Human Cancers
    Simone Patergnani et al, 2021, Cancers CrossRef
  9. HMGB Proteins from Yeast to Human. Gene Regulation, DNA Repair and Beyond
    Vizoso-Vázquez Ángel et al, 2017, Old Yeasts - New Questions CrossRef
  10. Relationship of High-mobility group box 1 levels and multiple sclerosis: A systematic review and meta-analysis
    Chao Zhen et al, 2019, Multiple Sclerosis and Related Disorders CrossRef
  11. MicroRNAs as the pivotal regulators of Temozolomide resistance in glioblastoma
    Mahsa Palizkaran Yazdi et al, 2024, Molecular Brain CrossRef
  12. MicroRNA‑30a increases the chemosensitivity of U251 glioblastoma cells to temozolomide by directly targeting beclin�1 and inhibiting autophagy
    Jing Xu et al, 2018, Experimental and Therapeutic Medicine CrossRef
  13. Retracted: HMGB1 regulates SNAI1 during NSCLC metastasis, both directly, through transcriptional activation, and indirectly, in a RSF1‐IT2‐dependent manner
    Xiao‐jin Wu et al, 2020, Molecular Oncology CrossRef
  14. SIRT6-PARP1 is involved in HMGB1 polyADP-ribosylation and acetylation and promotes chemotherapy-induced autophagy in leukemia
    Qian Kong et al, 2020, Cancer Biology & Therapy CrossRef
  15. Lucidone inhibits autophagy and MDR1 via HMGB1/RAGE/PI3K/Akt signaling pathway in pancreatic cancer cells
    Sheng‐Yi Chen et al, 2022, Phytotherapy Research CrossRef
  16. HMGB1: an important regulator of myeloid differentiation and acute myeloid leukemia as well as a promising therapeutic target
    Lulu Liu et al, 2021, Journal of Molecular Medicine CrossRef
  17. Platelet-Derived Growth Factor Regulates the Biological Behavior of Oral Mucosal Fibroblasts by Inducing Cell Autophagy and Its Mechanism
    Jie Wang et al, 2021, Journal of Inflammation Research CrossRef
  18. Poly (ADP‑ribosylation) of HMGB1 facilitates its acetylation and promotes HMGB1 translocation‑associated chemotherapy‑induced autophagy in leukaemia cells
    Yunyao Li et al, 2019, Oncology Letters CrossRef
  19. High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies
    Shunling Yuan et al, 2020, Journal of Hematology & Oncology CrossRef
  20. miR-505 enhances doxorubicin-induced cytotoxicity in hepatocellular carcinoma through repressing the Akt pathway by directly targeting HMGB1
    Lin Lu et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  21. Decreased Level of Klotho Contributes to Drug Resistance in Lung Cancer Cells: Involving in Klotho-Mediated Cell Autophagy
    TianJun Chen et al, 2016, DNA and Cell Biology CrossRef